Fig. 2
Clinical course of the patient after the first tocilizumab administration. NSAIDs non-steroidal anti-inflammatory drugs, PSL prednisolone, TCZ tocilizumab, TAC tacrolimus, KL-6 Krebs von den Lungen-6, iv intravenous
Fig. 2 | Allergy, Asthma & Clinical Immunology